Skip to content
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM

Our Publications

  • Our Broadcasts
  • Our Publications
  • Our Analyses
news2021-07-01T19:40:12+00:00

Young & Partner Article – Positive M&A to Continue in 2014 (ICIS Chemical Business Feb 24, 2014 issue)

Young & Partners' view of 2013 (M&A, financial and business) and the outlook for 2014

news2021-07-01T19:40:17+00:00

Dow Chemical Reports a Profit – Wall Street Journal (January 29, 2014)

Young & Partners comments on shareholder activist's premise about Dow Chemical

news2021-07-01T19:40:22+00:00

ICIS News – Activist premise on Dow spin false (January 27, 2014)

Young & Partners disagrees with shareholder activist premise about Dow Chemical

news2021-07-01T19:40:28+00:00

Pharma and Biotech Financial Trends: Every Which Way (Young & Partners article written for the Pharma Exec Dec 2013 Issue)

Article summarizing the latest business, M&A and financial developments in Biopharma

news2021-07-01T19:40:33+00:00

Activist Investors Target Chemicals (Young & Partners article in ICIS Oct. 1 – 13, 2013)

Perspectives on what these activists try to do and how should management react?

news2021-07-01T19:40:39+00:00

Chemical M&A Rebound Continues (Young & Partners article in ICIS Sept 30 – Oct 6, 2013)

Young & Partners describes the factors driving the ongoing rebound

news2021-07-01T19:40:45+00:00

Chemical M&A Market Revives (Young & Partners article in ICIS July 15 – 28, 2013)

Young & Partners article about what is driving the current chemical M&A revival

news2021-07-01T19:40:51+00:00

Sunny Outlook for Chemical Financing (Young & Partners article in ICIS Feb. 25 – March 3, 2013)

Overall chemical industry's debt and equity financing activity has been positive

news2021-07-01T19:40:56+00:00

Banker – M&A down in 2012, But Improving (Chemical Week Feb. 18, 2013 Issue)

Young & Partners' view of chemical industry M&A in 2012 and outlook for 2013

news2021-07-01T19:41:02+00:00

Chemical M&A Market Down But Not Out (Young & Partners article in ICIS Feb 11-17, 2013)

Unique insights about what happened last year and the positive outlook ahead

Previous131415Next

DISCLAIMER

JOIN OUR MAILING LIST

© YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017 | 212-682-5555

Page load link
Go to Top